NTX-301 in MDS/AML

Clinical trial NCT04167917 · COMPLETED

Trial details

NCT number: NCT04167917
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia

Start date: 2021-01-06
Primary completion: 2025-04-24
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.